Results 151 to 160 of about 3,160 (160)

Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium

Basic Research in Cardiology, 2022
Selin Gencer, Yvonne Döring, Yi Yan
exaly  

Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7

ACS Pharmacology and Translational Science, 2021
Max Meyrath, Christie B. Palmer, Alain F C Vanderplasschen   +2 more
exaly  

The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7

Signal Transduction and Targeted Therapy, 2021
Martyna Szpakowska, Max Meyrath, Christie B. Palmer   +2 more
exaly  

Cxcr4 and Ackr3 regulate allocation of caudal ganglionic eminence-derived interneurons to superficial cortical layers

Cell Reports, 2022
Philipp Abe, Ralf Stumm, Dagmar Schuetz
exaly  

The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers

Cytokine and Growth Factor Reviews, 2014
Aude Desnoyer, Françoise Bachelerie, Karl Balabanian   +2 more
exaly  

Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System

Molecular Pharmacology, 2019
Joyce Koenen, Françoise Bachelerie, Karl Balabanian   +2 more
exaly  

Functions of the CXCL12 Receptor ACKR3/CXCR7—What Has Been Perceived and What Has Been Overlooked

Molecular Pharmacology, 2020
Christian A Koch, Jürgen Engele
exaly  

Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists

Biochemical Pharmacology, 2018
Martyna Szpakowska, Max Meyrath, Nathan Reynders   +2 more
exaly  

Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12

International Journal of Molecular Sciences, 2018
Irene del Molino del Barrio, Annette Meeson, Simi Ali   +2 more
exaly  

MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia

Cell Metabolism
exaly